Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
The Huntington's Disease Association (HDA) is a prominent UK-based charity and patient advocacy organization dedicated to supporting individuals and families affected by Huntington's disease. Established in 1971, the association provides a comprehensive range of services, including specialist advisory support, educational programs for healthcare professionals, and advocacy for improved clinical care. While the HDA does not develop therapeutics directly, it is a vital stakeholder in the life sciences ecosystem, funding pilot research projects and facilitating patient recruitment for global clinical trials. The organization operates a network of specialist advisers across England and Wales to ensure coordinated care and support for the Huntington's community. By bridging the gap between patients and the research community, the HDA helps accelerate the development of potential treatments and remains the primary point of contact for Huntington's disease support within the United Kingdom.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Huntington's Disease Association.